Botulinum Toxin A for the Management of Post-Laryngectomy Salivary Leak and Pharyngocutaneous Fistula: A Case Series and Narrative Review
Open Access
- 10 October 2026
- journal article
- review article
- Published by MDPI AG in Journal of Otorhinolaryngology, Hearing and Balance Medicine
- Vol. 7 (2) , 37
Abstract
Post-laryngectomy salivary leak and pharyngocutaneous fistula (PCF) are recognised complications that prolong hospitalisation, delay adjuvant treatment and, in severe cases, risk major vessel exposure; current management relies on conservative measures or systemic anticholinergic agents, which carry a substantial burden of unwanted effects. We present four consecutive patients treated with a standardised regimen of botulinum toxin A (BoNT) injected into the parotid tail, parotid body and submandibular gland after failure of conservative management for post-laryngectomy salivary leak/PCF; all four achieved clinical and radiological resolution without significant local or systemic complications. We conducted a narrative review of the literature (PubMed, EMBASE, Cochrane, Google Scholar) using a structured search and screening process, screening 1198 records (701 after deduplication) and identifying 13 eligible studies (231 patients who received BoNT across 12 primary studies) evaluating BoNT for salivary leak/fistula across post-laryngectomy PCF and post-parotidectomy sialocele/fistula populations. A previous systematic review is discussed as supporting context; its patient cohort is not included in the total above, as its 27 source articles may overlap with the primary studies included in this review. Across the case series and a limited, predominantly observational literature base, BoNT was associated with rapid salivary suppression (up to ~95% reduction in one study), high fistula closure rates (54–100%), and accelerated healing, including a statistically significant reduction in healing time in one comparative study (18.5 vs. 26 days, p = 0.008); adverse events were reported as rare and minor, though these findings warrant cautious interpretation given the evidence base. BoNT injection is a low-risk, potentially high-yield adjunct for post-laryngectomy salivary leak and PCF, avoiding the systemic anticholinergic burden of alternative pharmacological treatments; multicentre studies with standardised dosing protocols are needed to establish its role in standard practice.Keywords
All Related Versions
This publication has 32 references indexed in Scilit:
- Intraglandular botulinum toxin in postoperative head and neck fistula: a retrospective analysisEuropean Archives of Oto-Rhino-Laryngology, 2024
- Association between postoperative complications and long‐term oncologic outcomes following total laryngectomy: 10‐year experience at MD Anderson Cancer CenterCancer, 2020
- Botulinum toxin A is an effective therapeutic tool for the management of parotid sialocele and fistula: A systematic reviewLaryngoscope Investigative Otolaryngology, 2020
- Intraductal Salivary Gland Infusion With Botulinum ToxinLaryngoscope Investigative Otolaryngology, 2019
- Complications, hospital length of stay, and readmission after total laryngectomyCancer, 2016
- Pharyngocutaneous fistula after total laryngectomy: Systematic review of risk factorsHead & Neck, 2015
- Preventing pharyngo‐cutaneous fistula in total laryngectomy: A systematic review and meta‐analysisThe Laryngoscope, 2013
- Botulinum toxin treatment of salivary fistulas following parotidectomy: follow-up resultsOral and Maxillofacial Surgery, 2012
- Assessment and incidence of salivary leak following laryngectomyThe Laryngoscope, 2012
- A Pilot Study Evaluating the Treatment of Postparotidectomy Sialoceles With Botulinum Toxin Type AJAMA Otolaryngology–Head & Neck Surgery, 2000